Quantbot Technologies LP Decreases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Quantbot Technologies LP reduced its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 79.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,062 shares of the medical equipment provider’s stock after selling 15,763 shares during the quarter. Quantbot Technologies LP’s holdings in Intuitive Surgical were worth $2,120,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the company. Bennett Selby Investments LP increased its position in Intuitive Surgical by 3.9% in the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares during the last quarter. Onefund LLC grew its position in shares of Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after purchasing an additional 18 shares in the last quarter. LVW Advisors LLC grew its position in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its position in shares of Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares in the last quarter. Finally, FSM Wealth Advisors LLC grew its position in shares of Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 19 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on ISRG. Leerink Partners lifted their price target on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Barclays lifted their price objective on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Trading Up 0.1 %

NASDAQ ISRG opened at $492.49 on Monday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock has a 50-day moving average of $562.24 and a 200-day moving average of $532.03. The firm has a market cap of $175.41 billion, a PE ratio of 76.83, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.